Cargando…
Effectiveness of nirmatrelvir-ritonavir for the treatment of patients with mild to moderate COVID-19 and at high risk of hospitalization: Systematic review and meta-analyses of observational studies
OBJECTIVE: To assess the effectiveness of nirmatrelvir-ritonavir in the treatment of outpatients with mild to moderate COVID-19 who are at higher risk of developing severe illness, through a systematic review with meta-analyses of observational studies. METHODS: A systematic search was performed, in...
Autores principales: | Souza, Kathiaja Miranda, Carrasco, Gabriela, Rojas-Cortés, Robin, Michel Barbosa, Mariana, Bambirra, Eduardo Henrique Ferreira, Castro, José Luis, Alvares-Teodoro, Juliana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569636/ https://www.ncbi.nlm.nih.gov/pubmed/37824507 http://dx.doi.org/10.1371/journal.pone.0284006 |
Ejemplares similares
-
Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study
por: Gentile, Ivan, et al.
Publicado: (2022) -
Nirmatrelvir-ritonavir for COVID-19
por: McDonald, Emily G, et al.
Publicado: (2022) -
Nirmatrelvir and ritonavir for COVID-19
Publicado: (2022) -
Nirmatrelvir Plus Ritonavir: First Approval
por: Lamb, Yvette N.
Publicado: (2022) -
Possible medication error risks with nirmatrelvir+ritonavir
Publicado: (2022)